Previous studies demonstrated that the impairment of BMPR2 signaling contributes to a PAH-like phenotype [89]; thus, the modulation of BMPR2 signaling using gene transfers represents a promising treatment strategy. Here, BMPR2 is linked to pulmonary arterial hypertension.